Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunology and immunopathology of COVID-19
Miriam Mérad, Catherine A. Blish, Federica Sallusto, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1122-1127
Open Access | Times Cited: 698

Showing 1-25 of 698 citing articles:

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, et al.
JAMA (2023) Vol. 329, Iss. 22, pp. 1934-1934
Open Access | Times Cited: 559
Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 420
Long-term neurologic outcomes of COVID-19
Evan Xu, Yan Xie, Ziyad Al‐Aly
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2406-2415
Open Access | Times Cited: 394
The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100663-100663
Open Access | Times Cited: 322
The protein corona from nanomedicine to environmental science
Morteza Mahmoudi, Markita P. Landry, Anna Moore, et al.
Nature Reviews Materials (2023) Vol. 8, Iss. 7, pp. 422-438
Open Access | Times Cited: 298
Serotonin reduction in post-acute sequelae of viral infection
Andrea C. Wong, Ashwarya S. Devason, Iboro C. Umana, et al.
Cell (2023) Vol. 186, Iss. 22, pp. 4851-4867.e20
Open Access | Times Cited: 227
Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
JAMA Internal Medicine (2023) Vol. 183, Iss. 6, pp. 554-554
Open Access | Times Cited: 219
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 218
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Carlo Cervia, Sarah C. Brüningk, Tobias Hoch, et al.
Science (2024) Vol. 383, Iss. 6680
Open Access | Times Cited: 206
Long COVID: mechanisms, risk factors and recovery
Rónan Astin, Amitava Banerjee, Mark R. Baker, et al.
Experimental Physiology (2022) Vol. 108, Iss. 1, pp. 12-27
Open Access | Times Cited: 172
Humoral Innate Immunity and Acute-Phase Proteins
Alberto Mantovani, Cecília Garlanda
New England Journal of Medicine (2023) Vol. 388, Iss. 5, pp. 439-452
Open Access | Times Cited: 152
Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations
Matteo Parotto, Mariann Gyöngyösi, Kathryn L. Howe, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 739-754
Open Access | Times Cited: 139
Long covid—an update for primary care
Trisha Greenhalgh, Manoj Sivan, Brendan Delaney, et al.
BMJ (2022), pp. e072117-e072117
Open Access | Times Cited: 132
Psychiatric and neurological complications of long COVID
Jolanta B. Zawilska, K Kuçzyńska
Journal of Psychiatric Research (2022) Vol. 156, pp. 349-360
Open Access | Times Cited: 109
Long-term gastrointestinal outcomes of COVID-19
Evan Xu, Yan Xie, Ziyad Al‐Aly
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 100
Risks and burdens of incident dyslipidaemia in long COVID: a cohort study
Evan Xu, Yan Xie, Ziyad Al‐Aly
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 2, pp. 120-128
Open Access | Times Cited: 88
Stopping pandemics before they start: Lessons learned from SARS-CoV-2
A.M. Edwards, Ralph S. Baric, Erica Ollmann Saphire, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1133-1139
Open Access | Times Cited: 85
Molnupiravir and risk of post-acute sequelae of covid-19: cohort study
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
BMJ (2023), pp. e074572-e074572
Open Access | Times Cited: 82
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 80
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 78
A new paradigm is needed to explain long COVID
Chloe Saunders, Søren Pedersen, Elisabeth Bendstrup
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 2, pp. e12-e13
Closed Access | Times Cited: 78
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
Jason Ross, Lara Myers, Joseph J. Noh, et al.
Nature (2024) Vol. 628, Iss. 8006, pp. 162-170
Closed Access | Times Cited: 78
S1-Leitlinie Long-/Post-COVID
Andreas Rembert Koczulla, Tobias Ankermann, Uta Behrends, et al.
Pneumologie (2022) Vol. 76, Iss. 12, pp. 855-907
Open Access | Times Cited: 77
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 76
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 239-255
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top